but these diverse calcium channel blockers also have markedly different pharmacological properties. To have an effect on dopaminergic neurons within the SnC calcium channel blockers must penetrate ...

A new study suggests that amlodipine, a widely used blood pressure medication, could help manage ADHD symptoms.

Clinical Relevance in Human Populations: Polygenic risk score analysis using the UK Biobank demonstrated that individuals with a high ADHD genetic burden who were prescribed amlodipine exhibited ...

High blood pressure is a major health concern, affecting about 10% of adults worldwide. Many people with this condition rely ...

The drugs most frequently used by these patients were diuretics, converting enzyme inhibitors, calcium channel blockers (CCB), lipid-lowering agents, and salicylates. Eczema was significantly ...

and treatment with each of three other types of antihypertensive drugs -- a calcium-channel blocker (amlodipine), an angiotensin-converting enzyme inhibitor (lisinopril), and a peripheral a ...

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to ...

A recent study from Penn State and other research institutions suggests that some of the most commonly used drugs for high ...

an L-type calcium channel blocker (LTCC), as a foundation for a novel therapy for ADHD. The findings provide robust validation of 3Z's cutting-edge high-throughput drug discovery platform and ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder ...